The role of Ga68 PSMA PET/CT imaging in Lu177 PSMA treatment planning in metastatic castration-resistant prostate cancer

被引：0
|
作者：
Mehmet Erdogan
Sevim S. Sengul
Bulent Cetin
Mustafa Avcı
Samet Yagci
Ismail Ozkoç
Damla Ezgi Barikan
Mustafa Yildiz
机构：
[1] Suleyman Demirel University Faculty of Medicine,Department of Nuclear Medicine
[2] Suleyman Demirel University Faculty of Medicine,Division of Medical Oncology, Department of Internal Medicine
来源：
Annals of Nuclear Medicine | 2022年 / 36卷
关键词：
Lutetium-177 PSMA; Gallium-68 PSMA; Metastatic castration resistant prostate cancer; TL PSMA; PSMA TV;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：562 / 569
页数：7
相关论文
共 50 条
  • [41] Utility of 18F-FDG AND 68Ga-PSMA PET/CT prior to 177Lu-PSMA radioligand therapy in metastatic castration resistant prostate cancer: A prospective study
    Babu, A. S.
    Jaleel, J.
    Khan, D.
    Yadav, M. P.
    Ballal, S.
    Tripathi, M.
    Sagar, S.
    Sahoo, R. K.
    Bal, C. S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S504 - S504
  • [42] Impact of 68Ga-PSMA PET/CT in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with enzalutamide.
    Altavilla, Amelia
    Caroli, Paola
    Giunta, Emilio Francesco
    Scarpi, Emanuela
    Rossetti, Virginia
    Casadei, Chiara
    Lolli, Cristian
    Schepisi, Giuseppe
    Bleve, Sara
    Cursano, Maria Concetta
    Gasperoni, Lorenzo
    Matteucci, Federica
    De Giorgi, Ugo
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [43] Treatment efficacy and safety of 177Lu-PSMA Radioligand Therapy in Octogenarians with metastatic castration-resistant prostate cancer
    Langbein, T.
    Retz, M.
    D'Alessandria, C.
    Grigorascu, S.
    Hansen, K.
    Wester, H.
    Gschwend, J.
    Weber, W.
    Eiber, M.
    Tauber, R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S132 - S133
  • [44] Use of PSMA PET in metastatic castration-resistant prostate cancer (mCRPC)
    Jensen, A.
    Karunaratna, N.
    Wong, S.
    Shapiro, J.
    Weickhardt, A.
    Spain, L.
    Azad, A. A.
    Kwan, E.
    Muthusamy, A.
    Torres, J.
    Parente, P.
    Francis, P.
    Parnis, F. X.
    Goh, J.
    Gibbs, P.
    Tran, B.
    Anton, A.
    ANNALS OF ONCOLOGY, 2020, 31 : S1329 - S1330
  • [45] Evaluating response to radium-223 using 68Ga-PSMA PET/CT imaging in patients with metastatic castration-resistant prostate cancer
    Shagera, Qaid Ahmed
    Gil, Thierry
    Barraco, Elisa
    Boegner, Petra
    Kristanto, Paulus
    El Ali, Ziad
    Sideris, Spyridon
    Chanza, Nieves Martinez
    Roumeguere, Thierry
    Flamen, Patrick
    Artigas, Carlos
    ANNALS OF NUCLEAR MEDICINE, 2025, 39 (02) : 208 - 216
  • [46] Dosimetry of 177Lu-PSMA-617 for the treatment of metastatic castration-resistant prostate cancer: A substudy of the VISION trial
    Kurth, Jens
    Herrmann, Ken
    Eiber, Matthias
    Rahbar, Kambiz
    Heuschkel, Martin
    Lassmann, Michael
    Jentzen, Walter
    Chicco, Daniela
    Messmann, Richard
    Sartor, A. Oliver
    Morris, Michael J.
    Krause, Bernd J.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [47] Lutetium-177-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer
    Sartor, Oliver
    de Bono, Johann
    Chi, Kim N.
    Fizazi, Karim
    Herrmann, Ken
    Rahbar, Kambiz
    Tagawa, Scott T.
    Nordquist, Luke T.
    Vaishampayan, Nitin
    El-Haddad, Ghassan
    Park, Chandler H.
    Beer, Tomasz M.
    Armour, Alison
    Perez-Contreras, Wendy J.
    DeSilvio, Michelle
    Kpamegan, Euloge
    Gericke, Germo
    Messmann, Richard A.
    Morris, Michael J.
    Krause, Bernd J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (12): : 1091 - 1103
  • [48] PSA flare in patients with metastatic castration-resistant prostate cancer undergoing 177Lu-PSMA treatment.
    Li, Haoran
    Wulff-Burchfield, Elizabeth Marie
    Abbasi, Saqib
    Narang, Arshit
    Dal, Emre
    Donald, Joseph
    Yap, Wendell Y.
    Shen, Xinglei
    Chen, Ronald C.
    Parikh, Rahul Atul
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 157 - 157
  • [49] Treatment response evaluation with PSMA-PET/CT imaging in patients with metastatic castration-resistant prostate cancer (mCRPC)
    Kleiburg, F.
    De Geus-Oei, L. F.
    Luelmo, S. A. C.
    Spijkerman, R.
    Toonen, F. A. J.
    Smit, F.
    Van der Hulle, T.
    Heijmen, L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S540 - S540
  • [50] FDG and PSMA PET in metastatic castration-resistant prostate cancer (mCRPC)
    Zukotynski, Katherine A.
    Jadvar, Hossein
    Cho, Steve Y.
    Kim, Chun Ki
    Cline, Kathryn
    Emmenegger, Urban
    Hotte, Sebastien J.
    Pond, Gregory Russell
    Winquist, Eric
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
12345